Log In
Print
BCIQ
Print
Print this Print this
 

MYC DsiRNA (DCR-M1711)

  Manage Alerts
Collapse Summary General Information
Company Dicerna Pharmaceuticals Inc.
DescriptionDicer substrate short interfering RNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc) mRNA
Molecular Target v-myc myelocytomatosis viral oncogene homolog (MYC) (c-Myc)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today